Day 1 articles

TAVI at 10 Years: First Study to Assess TAVI Long Term Durability

TAVI at 10 Years: First Study to Assess TAVI Long Term Durability

Original Title: First look at long-term durability of transcatheter heart valves: Assessment of valve function up to 10 years after implantation. Presenter: Danny Dvir.   Transcatheter aortic valve implantation (TAVI) is being used in increasingly younger patients at low surgical risk, which is why longer survival is expected. The durability of transcatheter aortic prostheses has

OPINON: OCT vs. IVUS Guided PCI

Original Title: Optical frequency domain imaging vs. IVUS in PCI: the OPINION trial – one-year primary endpoint results. Presenter: T. Kubo.   Optical coherence tomography (OCT) is increasingly being used in the daily practice given its greater capacity to define anatomical structures vs. intravascular ultrasound (IVUS). The clinical impact of this decision remains unclear.  

LEADERS FREE ACS: Biolimus coated stent vs. bare metal stent in ACS with high bleeding risk

Original Title: Biolimus A9 drug-coated stent vs. bare metal stent in patients presenting with ACS. A pre-specified LEADERS FREE ACS sub-study. Presenter: C.K. Naber.   In ACS patients with high bleeding risk, guidelines recommend 3 to 6 months of dual ATP treatment for DES implantation or one month in case of conventional stenting.   The

EWOLUTION: Outcomes of left atrial appendage closure in the real world

Original Title: EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe. Presenter: Martin Bergmann.   This study presented the experience of left atrial appendage closure with the WATCHMAN device outside the selected population of prior randomized clinical trials. The study included more than 1000 patients in this single arm multicenter registry;

Top